Skip to content

TAG and LAT CAB Welcome Indian Patent Office Decision That Could Expand Access to Hepatitis C Treatment

  • Jason Kirk

TAG and the Long-Acting Therapies Community Advisory Board (LAT CAB) welcomed a decision by the Indian Patent Office rejecting a patent application related to the hepatitis C treatment combination glecaprevir/pibrentasvir (G/P). Advocates say the decision could help reduce barriers to generic competition, lower treatment costs, and expand access to hepatitis C treatment in low- and middle-income countries disproportionately affected by the epidemic.

Read more

Financing Health Equity

  • Adam Ortega

The Promise and Potential of Economic Reforms for health The collapse of global health aid in 2025 revealed the fragility of health financing. Despite successes against TB and HIV in recent years, health aid from bilateral and multilateral donors has…

Read more

Research Toward a Cure Trials

  • Jason Kirk

Ending HIV requires sustained research. TAG’s May 2026 cure trials update tracks clinical studies worldwide, helping advocates, researchers, and communities follow progress toward a cure.

Read more

TAG Public Comments for the AIDS Research Advisory Council (ARAC) Meeting, April 6, 2026: Renewing Funding for the HIV Clinical Trial Networks

  • Adam Ortega

TAG recommends that the AIDS Research Advisory Council (ARAC) endorse NIAID's continued support of a balanced and comprehensive portfolio of basic, clinical, and implementation science — including a funding opportunity to renew its four current networks: the Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG), the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT), the HIV Prevention Trials Network (HPTN), and the HIV Vaccine Trials Network (HVTN) or the updated IBPTN.

Read more

Near Point-of-Care TB Tests: What Communities Need to Know and Advocate for in Global Fund Grant Cycle 8

  • Adam Ortega

TB testing is getting faster, cheaper, and more accessible and advocates have a critical window to act. Treatment Action Group's new factsheet breaks down WHO-recommended near point-of-care TB tests and shows how communities can use Global Fund Grant Cycle 8 to finance their rollout. With an estimated 2.7 million people going undiagnosed in 2024 alone, the tools and funding are finally aligned. Now is the time to push for change.

Read more

World Tuberculosis Day 2026

  • Adam Ortega

On World TB Day, TAG is excited to share our most recent TB vaccine materials: a new TB vax-zine, community partnership report on emerging vaccines, supply chain analysis of adjuvants that boost vaccine effectiveness, and the most recent pipeline report on TB vaccines in development.

Read more
Back To Top